Remimazolam vs Etomidate: Haemodynamic Effects in Hypertensive Elderly Patients Undergoing Non-Cardiac Surgery
Drug Design, Development and Therapy · 2023
DOI: 10.2147/dddt.s425590 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Drug Design, Development and Therapy, 2023. Verfasst von Jiejuan Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Anesthesiology, Guizhou Medical University, Guiyang City, Guizhou Province, People's Republic of China. Hauptthemen laut MEDLINE: Etomidate, Myoclonus, Hypertension, Propofol. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Anesthesiology, Guizhou Medical University, Guiyang City, Guizhou Province, People's Republic of China.
- Department of Anesthesiology, Affiliated Hospital of Guizhou Medical University, Guiyang City, Guizhou Province, People's Republic of China.
ORCID-Profile: Bailong Hu
Zitieren
APA
Chen, J., Zou, X., Hu, B., Yang, Y., Wang, F., Zhou, Q., & Shen, M. (2023). Remimazolam vs Etomidate: Haemodynamic Effects in Hypertensive Elderly Patients Undergoing Non-Cardiac Surgery. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s425590
Vancouver
Chen J, Zou X, Hu B, Yang Y, Wang F, Zhou Q, et al. Remimazolam vs Etomidate: Haemodynamic Effects in Hypertensive Elderly Patients Undergoing Non-Cardiac Surgery. Drug Design, Development and Therapy. 2023. doi:10.2147/dddt.s425590
BibTeX
@article{Chen2023,
author = {Chen, Jiejuan and Zou, Xiaohua and Hu, Bailong and Yang, Yang and Wang, Feng and Zhou, Qian and Shen, Minhuan},
title = {Remimazolam vs Etomidate: Haemodynamic Effects in Hypertensive Elderly Patients Undergoing Non-Cardiac Surgery},
journal = {Drug Design, Development and Therapy},
year = {2023},
doi = {10.2147/dddt.s425590}
}
EUVIMED